ICH guideline
ICH E22 EWG: General Considerations for Patient Preference Studies
ICH guideline · Efficacy Guidelines · Step 3
Key facts
| ICH code | E22 EWG |
|---|---|
| Title | General Considerations for Patient Preference Studies |
| Guideline series | Efficacy Guidelines |
| ICH step | Step 3 |
| ICH summary (excerpt) | This topic was endorsed by the ICH Assembly in June 2023. Further to the ICH Management Committee’s endorsement of the E22 Concept Paper in June 2024, the E22 Guideline aims to optimise the use of patient preference information as input to pharmaceutical product development using a globally harmonised framework and… |
| File | Stakeholder Webinar Meeting Report |
| File type | |
| File on ich.org | database.ich.org |
At a glance
- Yes Full text searchable in Orca1
- Stakeholder Webinar Meeting Report Files published by ICH
- None FDA guidance documents based on this guideline
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ICH guidelines
ICH guidelines harmonise the technical requirements for registering medicines in the ICH regions. Each guideline moves through a five-step process, from concept paper to adoption and implementation by regulators.